fashion -WSS

fashion

author：comprehensive 2025-10-01 15:28:30 - browse：6

Stephen Quake: "Our North Star for the next decade is understanding the mysteries of the cell." Chan Zuckerberg Initiative

SAN DIEGO — Decades ago, as a young physics Ph.D. student, Stephen Quake stumbled into the messy, dazzlingly complicated world of biology — and he’s stayed there ever since.

Quake, a professor of bioengineering and applied physics at Stanford, is a prolific academic whose discoveries have fueled the field of blood-based prenatal testing and the use of microfluidic chips, which allow scientists to quickly analyze DNA, RNA, proteins, and cells. He’s also head of science for the Chan Zuckerberg Initiative, or CZI, a company Mark Zuckerberg and Priscilla Chan founded in 2015 with the expressed intent to help “cure, prevent or manage all diseases by the end of this century.” The organization funds academic research and operates three biohubs in San Francisco, Chicago, and New York, each centered on goals such as building cells that can survey the body for signs of disease or deciphering the signals that drive inflammatory disease.

STAT sat down with Quake in front of an audience during the annual meeting of the Biotechnology Innovation Organization for a fireside chat about his pivot into the life sciences — and his second unexpected journey into the world of philanthropy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： DeepMind touts AlphaFold's new skills as protein folding AI models face off

WSS

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

What is microchimerism and how does it affect maternal health?

Why Novartis is going to walk from its acquisition of MorphoSys

Medicare Advantage plans can’t deny care with AI, CMS warns

Adopting new red light myopia treatments may be short

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Walensky prepares to leave CDC — and Congress — behind

Readout LOUD podcast: ESMO highlights & Roivant's big deal

After affirmative action ruling, medical educators look to 'holistic review'

The health care issue Democrats can’t solve: hospital reform

Medical leaders decry Supreme Court decision on affirmative action

How to convince healthy people to buy insurance

After affirmative action ruling, medical educators look to 'holistic review'

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

All of Us, NIH's precision medicine initiative, gets a big boost

focus

340B reform proposal comes out of Senate working group

340B reform proposal comes out of Senate working group

Brain injuries and the importance of a second opinion

Explaining an after

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Life sciences investors close nearly $6 billion in new funds

explore

focus

focus

focus